Latest News
-
Monday - January 14, 2013
Not intended for US or UK use - JEADV publishes European dermatologists’ call for paradigm shift in acne treatment
Adult female acne requires different treatment from adolescent acne
Consensus has been reached on the treatment of adult female acne / Need to tailor treatment to specific characteristics » more
-
Thursday - January 10, 2013
Focus on new polycarbonate applications for Korean companies:
Bayer opens Polymer Development Center in South Korea
Further strengthening presence in Asia Pacific » more
-
Thursday - January 10, 2013
Awards from the Bayer Science & Education Foundation
Bayer Early Excellence in Science Award 2012: EUR 30,000 for young research scientists
Dr. Christiane Opitz (German Cancer Research Center, Heidelberg) wins the „Biology“ category / Dr. Nuno Maulide (Max Planck Institut für Kohlenforschung, Mühlheim an der Ruhr) takes the „Chemistry“ award / Dr. Volker Presser (Leibniz Institute for New Materials, Saarbrücken) awarded prize in the „Materials“ field » more
-
Thursday - January 10, 2013
Not intended for U.S. and UK media
Bayer receives approval for new long-term contraceptive Skyla™ in the U.S.
New low dose levonorgestrel-releasing intrauterine system (IUS) / Longterm contraception for up to three years » more
-
Tuesday - January 8, 2013
Further milestone to becoming a leading provider of integrated crop solutions:
Bayer CropScience acquires Germany-based biocontrol company Prophyta GmbH » more
-
Tuesday - January 8, 2013
Network partners in the EcoCommercial Building Program support TU Berlin research project
Upcycled polyurethane panels used for the first time in composite façade
Innovative solutions for sustainable building » more
-
Tuesday - January 8, 2013
Closer collaboration with network partners to better leverage innovative ideas
Bayer MaterialScience expands EcoCommercial Building Program into a development network
Solar air collector roof insulating system as an example of a sustainable solution for the building industry » more
-
Monday - January 7, 2013
Following a detailed appraisal by the Cologne district authority:
Bayer gets the green light to build and operate the new world-scale TDI plant in Dormagen » more
-
Monday - January 7, 2013
Not intended for U.S. and UK media
Bayer Submits VEGF Trap-Eye (aflibercept) for Treatment of Macular Edema Following Central Retinal Vein Occlusion in Japan » more
-
Friday - January 4, 2013
Not intended for U.S. media
Bayer HealthCare completes acquisition of Teva’s U.S. animal health business
New product lines strengthen Bayer’s animal health business in the U.S. » more
-
Thursday - January 3, 2013
Not intended for U.S. and UK media
Phase III DECISION Trial of Nexavar® (sorafenib) Meets Primary Endpoint of Improving Progression-Free Survival in Patients with Radioactive Iodine Refractory Differentiated Thyroid Cancer » more
-
Friday - December 21, 2012
Not intended for U.S. and UK Media
Bayer Submits Regorafenib for the Treatment of Gastrointestinal Stromal Tumors in Japan » more
-
Wednesday - December 19, 2012
Bayer optimizes its use of liquidity
Group contributes EUR 1 billion to Bayer Pension Trust » more
-
Tuesday - December 18, 2012
New polycarbonate grades for furniture are clear winners
Bayer MaterialScience fulfills the wish of modern designers » more
-
Friday - December 14, 2012
Not intended for U.S. and UK Media
Bayer Submits New Drug Application to U.S. FDA for Radium-223 Dichloride for the Treatment of Castration-Resistant Prostate Cancer with Bone Metastases
Radium-223 dichloride now submitted for Marketing Authorization in EU and US » more
-
Friday - December 14, 2012
Michael Koenig appointed to the Bayer Board of Management
Dr. Richard Pott to retire effective June 1, 2013 » more
-
Thursday - December 13, 2012
Bayer CropScience hosts inaugural Vegetable Future Forum in Monheim:
Partnerships key to success of global vegetable food value chain » more
-
Wednesday - December 12, 2012
Not intended for U.S. and UK Media
Bayer Submits Radium-223 Dichloride for EU Marketing Authorization for the Treatment of Castration-Resistant Prostate Cancer with Bone Metastases » more
-
Monday - December 10, 2012
Distinction for outstanding HR marketing activities:
Bayer JobApp wins HR Excellence Award » more
-
Thursday - December 6, 2012
Innovative and flexible solutions for reducing vehicle fleet CO2:
Bayer awarded International Fleet Green Award once again
Objective achieved ahead of deadline: 20 percent reduction in CO2 emissions of vehicle fleet since 2008 » more
Copyright @ Bayer AG
Search
Publications
research – The Bayer Scientific Magazine
Stockholders' Newsletter
Annual Report
Sustainable Development Report
Publications Overview
Newsletter
Events
Download Center - Selection
Bayer TV